Reported immune alterations in multiple myeloma include defects in T cell function, a reduction of peripheral CD4+ and CD8+ T cells, abnormal Th1/Th2 ratio, a decrease in CD4/CD8 T cell ratio and a reduction in NKT cells (33). The gene discussed is CD4; the disease is plasma cell myeloma.